ReproCELL Incorporated (TYO:4978)

Japan flag Japan · Delayed Price · Currency is JPY
180.00
-3.00 (-1.64%)
Apr 17, 2026, 3:30 PM JST
Market Cap17.11B +20.4%
Revenue (ttm)2.52B -7.3%
Net Income-324.00M
EPS-3.42
Shares Out95.03M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume433,500
Average Volume723,965
Open182.00
Previous Close183.00
Day's Range178.00 - 183.00
52-Week Range134.00 - 242.00
Beta0.62
RSI52.86
Earnings DateMay 13, 2026

About ReproCELL

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 99
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4978
Full Company Profile

Financial Performance

Financial Statements